EUCTR2015-001635-21-DKActive, not recruitingPhase 1
ordic Pancreatic Cancer Trial - NorPACT-1
orwegian Gastointestinal Cancer Group0 sites140 target enrollmentStarted: February 5, 2019Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 140
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Resectable pancreatic cancer
- •Performance status 0-2
- •Histologically confirmed diagnosis
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 70
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 70
Exclusion Criteria
- •Metastatic disease
- •Non-resectable primary pancreatic cancer
Investigators
Similar Trials
Active, not recruiting
Not Applicable
orwegian Pancreatic Cancer TrialResectable pancreatic cancerMedDRA version: 18.0Level: LLTClassification code 10033604Term: Pancreatic cancerSystem Organ Class: 100000004864EUCTR2015-001635-21-NOorwegian Gastointestinal Cancer Group
Active, not recruiting
Phase 1
orPACT-1Resectable pancreatic cancerMedDRA version: 20.0Level: LLTClassification code 10007071Term: Cancer of head of pancreasSystem Organ Class: 100000004864EUCTR2015-001635-21-SESwedish studygroup for pancreatic cancer (SSPAC)126
Recruiting
Phase 2
PAT-07Borderline resectable pancreatic cancerBorderline resectable, pancreatic cancerD021441JPRN-jRCTs041200028Kodera Yasuhiro50
Recruiting
Phase 2
agoya University Pancreatic Tumor Board trial 08ocally advanced pancreatic cancerJPRN-jRCTs041200054Kodera Yasuhiro50
Active, not recruiting
Not Applicable
A trial comparing the current standard treatment (gemcitabine) to the experimental, combined treatments of gemcitabine plus capecitabine.Resectable pancreatic or peri-ampullary cancersMedDRA version: 14.1Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10034446Term: Periampullary carcinoma resectableSystem Organ Class: 100000004864EUCTR2007-004299-38-GBThe University of Liverpool1,396